Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 9, 2004Cerebrovascular Diseases

Prothrombin 20210A and Oral Contraceptive Use as Risk Factors for Cerebral Venous Thrombosis

View Full Paper
Ask AI
Bookmark
Share

Authors

TGTelma GadelhaUniversidade Federal do Rio de JaneiroCACharles AndréCentre Hospitalier du MansAJA Juca

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gadelha et al. (2004) studied this question.

synapsesocial.com/papers/6a707044fe4101aa97e0293fhttps://doi.org/10.1159/000081911
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Risk Factors in Venous Thromboembolism2001 · 298 citations
  2. 2Investigation of relation between use of oral contraceptives and thromboembolic disease.1968 · 473 citations
  3. 3Coagulation Studies, Factor V Leiden, and Anticardiolipin Antibodies in 40 Cases of Cerebral Venous Thrombosis1996 · 275 citations
  4. 4Screening for thrombophilic risk factors among 25 German patients with cerebral venous thrombosis2000 · 50 citations
  5. 5Geographic Distribution of the 20210 G to A Prothrombin Variant1998 · 704 citations